VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Operating income, 2025
- $4.2B
- 5-year CAGR
- +7.9%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $4.2B | — |
| 2024 | −$233M | — |
| 2023 | $3.8B | −11.0% |
| 2022 | $4.3B | +54.8% |
| 2021 | $2.8B | −2.6% |
| 2020 | $2.9B | +138.5% |
| 2019 | $1.2B | +88.5% |
| 2018 | $635M | +415.4% |
| 2017 | $123M | +1,140.4% |
| 2016 | $9.9M | — |
| 2015 | −$467M | — |
| 2014 | −$692M | — |
| 2013 | −$610M | — |
| 2012 | $47M | −58.9% |
| 2011 | $114M | — |
| 2010 | −$696M | — |
| 2009 | −$614M | — |
| 2008 | −$463M | — |